Browsing Tag
GIP
7 posts
Is Eli Lilly the NVIDIA of healthcare? How metabolic drugs became the new AI trade
Discover how Eli Lilly and Company crossed the $1 trillion valuation mark and why its metabolic-health franchise is now being valued like a high-growth tech platform—read more now.
Why Eli Lilly (NYSE: LLY) just joined the $1tn club—and what it means for obesity drug stocks
Find out how Eli Lilly’s weight-loss drug surge has pushed it past a $1 trillion valuation—and what that means for the industry!
Can Lilly’s flat $499/month Zepbound pricing reshape obesity drug access in the U.S.?
Lilly expands Zepbound access via LillyDirect, offering all FDA-approved doses for $499/month. Explore the implications for patients and the GLP-1 drug market.
Palatin Technologies completes Phase 2 obesity trial with MC4R bremelanotide and GLP-1/GIP tirzepatide
Palatin Technologies, Inc. has announced the completion of its Phase 2 BMT-801 clinical trial, a study evaluating the…
A $100bn AI bet? Microsoft, BlackRock’s game-changing move in tech
BlackRock, Microsoft, Global Infrastructure Partners (GIP), and MGX have unveiled the Global AI Infrastructure Investment Partnership (GAIIP), a…
TC Energy to sell 40% interest in Columbia Gas systems to GIP in $5.2bn deal
TC Energy Corporation, a significant player in the energy sector listed on both TSX and NYSE, announced that…
KKR, GIP to take data center firm CyrusOne private in $15bn deal
KKR and Global Infrastructure Partners (GIP) have signed an all-cash deal worth around $15 billion to acquire CyrusOne,…